- Home
- SANG vs CATX Comparison
SANG vs CATX Comparison
Compare SANG & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- CATX
- Stock Information
- Founded
- SANG 1984
- CATX 1983
- Country
- SANG Canada
- CATX United States
- Employees
- SANG N/A
- CATX N/A
- Industry
- SANG Computer Software: Programming Data Processing
- CATX Medical/Dental Instruments
- Sector
- SANG Technology
- CATX Health Care
- Exchange
- SANG Nasdaq
- CATX Nasdaq
- Market Cap
- SANG 153.5M
- CATX 182.9M
- IPO Year
- SANG 2021
- CATX N/A
- Fundamental
- Price
- SANG $5.90
- CATX $2.34
- Analyst Decision
- SANG
- CATX Strong Buy
- Analyst Count
- SANG 0
- CATX 10
- Target Price
- SANG N/A
- CATX $13.89
- AVG Volume (30 Days)
- SANG 3.7K
- CATX 619.9K
- Earning Date
- SANG 05-08-2025
- CATX 05-12-2025
- Dividend Yield
- SANG N/A
- CATX N/A
- EPS Growth
- SANG N/A
- CATX N/A
- EPS
- SANG N/A
- CATX N/A
- Revenue
- SANG $241,243,000.00
- CATX $1,454,000.00
- Revenue This Year
- SANG N/A
- CATX N/A
- Revenue Next Year
- SANG $2.91
- CATX N/A
- P/E Ratio
- SANG N/A
- CATX N/A
- Revenue Growth
- SANG N/A
- CATX 1.40
- 52 Week Low
- SANG $4.08
- CATX $1.60
- 52 Week High
- SANG $7.99
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- SANG 67.39
- CATX 51.17
- Support Level
- SANG $5.67
- CATX $2.18
- Resistance Level
- SANG $5.97
- CATX $2.65
- Average True Range (ATR)
- SANG 0.13
- CATX 0.16
- MACD
- SANG 0.06
- CATX 0.02
- Stochastic Oscillator
- SANG 95.04
- CATX 56.25
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.